BRIEF-Cero Therapeutics Announces Critical Patent Application Allowances From The U.S. Patent Office

Reuters
10 Apr
BRIEF-Cero <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Critical Patent Application Allowances From The U.S. Patent Office

April 10 (Reuters) - CERo Therapeutics Holdings Inc CERO.O:

  • CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES CRITICAL PATENT APPLICATION ALLOWANCES FROM THE U.S. PATENT OFFICE COVERING COMPANY’S LEAD COMPOUND CER-1236

Source text: ID:nGNE64NCNq

Further company coverage: CERO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10